Loading...
Ion Beam Applications SA
IBAB.BR•EURONEXT
Healthcare
Medical - Devices
€12.00
€0.12(1.01%)
Ion Beam Applications SA (IBAB.BR) Financial Performance & Statements
Review Ion Beam Applications SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
16.21%
↑ 16.21%
Operating Income Growth
239.75%
↑ 239.75%
Net Income Growth
202.09%
↑ 202.09%
Operating Cash Flow Growth
49.42%
↑ 49.42%
Operating Margin
2.87%
↑ 2.87%
Gross Margin
33.32%
↑ 33.32%
Net Profit Margin
1.87%
↑ 1.87%
ROE
9.25%
↑ 9.25%
ROIC
9.72%
↑ 9.72%
Ion Beam Applications SA (IBAB.BR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Ion Beam Applications SA stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $498.20M | $428.72M | $361.27M | $312.96M |
| Cost of Revenue | $332.20M | $294.28M | $234.50M | $205.27M |
| Gross Profit | $166.00M | $134.44M | $126.77M | $107.69M |
| Gross Profit Ratio | $0.33 | $0.31 | $0.35 | $0.34 |
| R&D Expenses | $58.00M | $47.92M | $41.84M | $34.01M |
| SG&A Expenses | $90.70M | $80.10M | $73.88M | $59.17M |
| Operating Expenses | $148.70M | $129.35M | $115.72M | $93.18M |
| Total Costs & Expenses | -$480.90M | $423.63M | $350.22M | $298.45M |
| Interest Income | $0.00 | $1.65M | $3.00M | $1.99M |
| Interest Expense | $2.70M | $2.05M | $2.85M | $3.72M |
| Depreciation & Amortization | $11.70M | $11.52M | $10.71M | $9.89M |
| EBITDA | $26.70M | $12.53M | $13.13M | $23.12M |
| EBITDA Ratio | $0.05 | $0.03 | $0.06 | $0.08 |
| Operating Income | $17.30M | $5.09M | $11.05M | $14.51M |
| Operating Income Ratio | $0.03 | $0.01 | $0.03 | $0.05 |
| Other Income/Expenses (Net) | -$4.50M | -$5.41M | -$5.39M | -$5.22M |
| Income Before Tax | $12.80M | -$315000.00 | -$433000.00 | $9.51M |
| Income Before Tax Ratio | $0.03 | -$0.001 | -$0.001 | $0.03 |
| Income Tax Expense | $5.60M | $8.79M | -$6.49M | $4.38M |
| Net Income | $9.30M | -$9.11M | $6.06M | $3.88M |
| Net Income Ratio | $0.02 | -$0.02 | $0.02 | $0.01 |
| EPS | $0.31 | -$0.31 | $0.21 | $0.13 |
| Diluted EPS | $0.31 | -$0.31 | $0.20 | $0.13 |
| Weighted Avg Shares Outstanding | $30.28M | $29.13M | $29.14M | $29.42M |
| Weighted Avg Shares Outstanding (Diluted) | $30.28M | $29.13M | $30.18M | $30.16M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan